ExodusPoint Capital Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
ExodusPoint Capital Management's LLY Position: Q3 2026 in Review
ExodusPoint Capital Management sold out of Eli Lilly (LLY) in Q3 2026, closing a stake of 14,472 shares — an estimated $17.4M sold.
ExodusPoint Capital Management first reported a position in LLY in Q4 2018 and held it in 17 quarters. The position peaked at $28.2M in Q2 2022. 4,450 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- ExodusPoint Capital Management reported no remaining Eli Lilly position as of Q3 2026 after selling out during the quarter.
- ExodusPoint Capital Management sold 14,472 Eli Lilly shares in Q3 2026, an estimated $17.4M.
- ExodusPoint Capital Management first reported a position in Eli Lilly in Q4 2018 and held it in 17 quarters.
- ExodusPoint Capital Management's Eli Lilly position peaked at $28.2M in Q2 2022.
- 4,450 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on ExodusPoint Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.